Aphantasia, the inability to form mental images, poses a serious challenge to an influential theory of abstract thought in ...

Abstract recently submitted in anticipation of initial data analysis ahead of ESCCompany expects to report topline LEVEL results in AugustCHAPEL ...

Have you ever looked at an abstract painting and wondered what the artist was thinking? A splash of color on a canvas can ...

CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value ...

The ACGME has opened its Call for Sessions and will soon open the Call for Abstracts for the 2027 Annual Educational ...

DURHAM, N.C., June 4, 2026 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc., a biopharmaceutical company focused on advancing innovative treatments for people living with migraine, today announced that ...

This page provides answers to the most commonly asked questions regarding abstract submission, confidentiality, and presentation policies. Questions are listed together at the top of the page for ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that 37 abstracts have been accepted for presentation at the 2026 American ...

IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts—including one oral presentation—for the ...

Health Affairs is planning a theme in January 2027 that will explore The Path Forward For Public Health. Our June 2024 theme issue on the topic assessed the state of public health after the COVID-19 ...